BR100 Increased By (0.08%)
BR30 Increased By (0.22%)
KSE100 Increased By (0.04%)
KSE30 Increased By (0.08%)
BECO 5.53 Decreased By ▼ -0.01 (-0.18%)
BML 56.60 Decreased By ▼ -0.49 (-0.86%)
BOP 35.18 Decreased By ▼ -0.03 (-0.09%)
CNERGY 8.16 Decreased By ▼ -0.04 (-0.49%)
DCL 11.63 Decreased By ▼ -0.01 (-0.09%)
FCCL 56.80 Increased By ▲ 0.31 (0.55%)
FCSC 5.39 Increased By ▲ 0.07 (1.32%)
FFL 17.95 Decreased By ▼ -0.11 (-0.61%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.18 Decreased By ▼ -0.01 (-0.09%)
KEL 8.43 Increased By ▲ 0.23 (2.8%)
KOSM 6.60 Decreased By ▼ -0.07 (-1.05%)
MLCF 101.30 Increased By ▲ 0.54 (0.54%)
NBP 202.00 Decreased By ▼ -1.00 (-0.49%)
PACE 11.47 Decreased By ▼ -0.02 (-0.17%)
PAEL 43.32 Increased By ▲ 0.24 (0.56%)
PIAHCLA 27.32 Increased By ▲ 0.32 (1.19%)
PIBTL 17.78 Decreased By ▼ -0.06 (-0.34%)
PPL 244.65 Increased By ▲ 2.02 (0.83%)
PRL 35.80 Decreased By ▼ -0.07 (-0.2%)
PTC 65.81 Decreased By ▼ -0.04 (-0.06%)
SEARL 93.42 Decreased By ▼ -0.16 (-0.17%)
SSGC 32.95 Increased By ▲ 0.72 (2.23%)
TELE 9.00 Decreased By ▼ -0.11 (-1.21%)
THCCL 66.85 Increased By ▲ 0.36 (0.54%)
TPLP 10.85 Decreased By ▼ -0.10 (-0.91%)
TREET 25.47 Decreased By ▼ -0.25 (-0.97%)
TRG 65.89 Decreased By ▼ -0.06 (-0.09%)
WAVES 11.17 Increased By ▲ 0.01 (0.09%)
WTL 1.26 No Change ▼ 0.00 (0%)
World

Valneva says UK rollout of COVID-19 vaccine could start in July-Sept

  • Valneva said in September that its vaccine would be available for use in Britain in the second half of 2021.
Published January 17, 2021 Updated January 17, 2021 08:59pm
By

LONDON: French drugmaker Valneva hopes its COVID-19 vaccine can start to be used in Britain between July and September, the company's chief executive was quoted as saying.

Valneva has agreed to provide Britain with 60 million doses of its vaccine, compared with 100 million doses of the shot from AstraZeneca and Oxford University. It is expected to need a two-dose regimen.

"We are days away from starting the commercial manufacturing," Thomas Lingelbach told The Mail on Sunday newspaper.

"We cannot release it without regulatory approval so we're in a little bit of a Catch-22 situation and there are certainly scenarios that we are currently discussing with the regulators," he added. "But we have already signed up to give priority to the UK and this is something we're currently working on."

Valneva said in September that its vaccine would be available for use in Britain in the second half of 2021.

Britain has launched Europe's fastest rollout of COVID-19 vaccines and its foreign minister Dominic Raab said on Sunday the government hoped to ease some lockdown restrictions in March.

Comments

Comments are closed for this article.